0.68 - 0.75
0.33 - 0.86
18.34M / 4.66M (Avg.)
34.50 | 0.02
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-14.52%
Both firms have declining sales. Martin Whitman would suspect an industry slump or new disruptive entrants.
-5.64%
Both firms have negative gross profit growth. Martin Whitman would question the sector’s viability or cyclical slump.
-43.49%
Both companies show negative EBIT growth. Martin Whitman would consider macro or sector-specific headwinds.
-40.57%
Both companies face negative operating income growth. Martin Whitman would suspect broader market or cost hurdles.
-82.23%
Both companies face declining net income. Martin Whitman would suspect external pressures or flawed business models in the space.
-80.89%
Both companies exhibit negative EPS growth. Martin Whitman would consider sector-wide issues or an unsustainable business environment.
-82.21%
Both face negative diluted EPS growth. Martin Whitman would suspect an industry or cyclical slump with heightened share issuance across the board.
-7.43%
Share reduction while 0259.HK is at 0.00%. Joel Greenblatt would see if the company has a better buyback policy than the competitor.
0.01%
Diluted share change of 0.01% while 0259.HK is zero. Bruce Berkowitz might see a minor difference that could widen over time.
-100.00%
Dividend reduction while 0259.HK stands at 300.00%. Joel Greenblatt would question the firm’s cash flow stability or capital allocation decisions.
364.22%
OCF growth above 1.5x 0259.HK's 55.60%. David Dodd would confirm a clear edge in underlying cash generation.
237.08%
FCF growth above 1.5x 0259.HK's 45.78%. David Dodd would verify if the firm’s strategic investments yield superior returns.
75929.25%
10Y revenue/share CAGR above 1.5x 0259.HK's 196.44%. David Dodd would confirm if management’s strategic vision consistently outperforms the competitor.
33.05%
5Y revenue/share CAGR under 50% of 0259.HK's 578.74%. Michael Burry would suspect a significant competitive gap or product weakness.
4.30%
3Y revenue/share CAGR under 50% of 0259.HK's 36.98%. Michael Burry might see a serious short-term decline in relevance vs. the competitor.
2432.89%
10Y OCF/share CAGR above 1.5x 0259.HK's 91.81%. David Dodd would check if a superior product mix or cost edge drives this outperformance.
-19.33%
Negative 5Y OCF/share CAGR while 0259.HK is at 127.66%. Joel Greenblatt would question the firm’s operational model or cost structure.
78.77%
Positive 3Y OCF/share CAGR while 0259.HK is negative. John Neff might see a big short-term edge in operational efficiency.
170.51%
Net income/share CAGR above 1.5x 0259.HK's 84.13% over 10 years. David Dodd would confirm if brand, IP, or scale secure this persistent advantage.
118.16%
5Y net income/share CAGR similar to 0259.HK's 112.37%. Walter Schloss might see both on parallel mid-term trajectories.
158.20%
Positive short-term CAGR while 0259.HK is negative. John Neff would see a clear advantage in near-term profit trajectory.
No Data
No Data available this quarter, please select a different quarter.
240.50%
Equity/share CAGR of 240.50% while 0259.HK is zero. Bruce Berkowitz might see a minor advantage that could compound if the firm maintains positive net worth growth.
102.05%
Positive short-term equity growth while 0259.HK is negative. John Neff sees a strong advantage in near-term net worth buildup.
No Data
No Data available this quarter, please select a different quarter.
-100.00%
Negative 5Y dividend/share CAGR while 0259.HK stands at 25.00%. Joel Greenblatt sees a weaker commitment to dividends vs. a competitor that might be growing them.
-100.00%
Negative near-term dividend growth while 0259.HK invests at 399.97%. Joel Greenblatt sees a weaker short-term distribution policy unless justified by strategic spending.
No Data
No Data available this quarter, please select a different quarter.
72.56%
Inventory growth well above 0259.HK's 0.21%. Michael Burry suspects overshooting production or weaker sell-through vs. the competitor.
-2.91%
Negative asset growth while 0259.HK invests at 1.63%. Joel Greenblatt checks if the competitor might capture more market share unless our returns remain higher.
9.36%
BV/share growth above 1.5x 0259.HK's 3.04%. David Dodd confirms if consistent profit retention or fewer write-downs yield faster equity creation.
24.71%
Debt growth of 24.71% while 0259.HK is zero. Bruce Berkowitz sees additional leverage that must yield profitable expansions to be worthwhile.
-71.23%
Our R&D shrinks while 0259.HK invests at 9.86%. Joel Greenblatt checks if we risk falling behind a competitor’s new product pipeline.
1.54%
We expand SG&A while 0259.HK cuts. John Neff might see the competitor as more cost-optimized unless we expect big payoffs from the overhead growth.